WHO Approves Trials of Two Vaccines as DRC Ebola Outbreak Spreads
The World Health Organization has approved clinical trials of two vaccines designed to combat the Bundibugyo strain of Ebola amid a rapidly growing outbreak centered in the Democratic Republic of the Congo.
WHO expert groups recommended adding the two vaccine candidates to the response after the strain killed more than 5,300 people, mostly in the DRC, since the outbreak was declared in May, Al Jazeera reported. Earlier DRC Health Ministry data recorded 5,026 deaths among 10,351 infections, a fatality rate of nearly 50%. The Africa Centres for Disease Control and Prevention later reported 10,444 confirmed cases.
The trials are being led by the DRC’s National Institute for Biomedical Research with support from the WHO and other partners. The vaccines specifically target the Bundibugyo strain. Results are expected in early 2027. An earlier trial used Ervebo, a vaccine approved for the Zaire …